| Role of BRCA mutations in the modulation of response to platinum therapy S Mylavarapu, A Das, M Roy Frontiers in oncology 8, 16, 2018 | 146 | 2018 |
| Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12 AK Srivastava, S Choudhry, MS Gopinath, S Roy, M Tripathi, ... Annals of neurology 50 (6), 796-800, 2001 | 117 | 2001 |
| Identification of a novel 45 repeat unstable allele associated with a disease phenotype at the MJD1/SCA3 locus QS Padiath, AK Srivastava, S Roy, S Jain, SK Brahmachari American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 133 …, 2005 | 97 | 2005 |
| Post-zygotic de novo trinucleotide repeat expansion at spinocerebellar ataxia type 7 locus: evidence from an Indian family U Mittal, S Roy, S Jain, AK Srivastava, M Mukerji Journal of human genetics 50 (3), 155-157, 2005 | 32 | 2005 |
| Activation of epithelial-mesenchymal transition and altered β-catenin signaling in a novel Indian colorectal carcinoma cell line S Mylavarapu, H Kumar, S Kumari, LS Sravanthi, M Jain, A Basu, ... Frontiers in Oncology 9, 54, 2019 | 15 | 2019 |
| Supramolecular combinatorial therapeutics M Roy, S Hossain, A Sengupta, S Mylavarapu, S Sengupta, A Mukherjee US Patent 10,426,753, 2019 | 9 | 2019 |
| Role of BRCA mutations in the modulation of response to platinum therapy. Front Oncol. 2018; 8: 16 S Mylavarapu, A Das, M Roy | 5 | 2018 |
| IO125, a novel Pt-based supramolecular therapeutic exhibits increased anti-cancer efficacy compared with oxaliplatin M Roy, SS Hossain, A Sarkar, A Sengupta, N Gupta, S Hussain, A Ansari, ... Cancer Research 74 (19_Supplement), 4483-4483, 2014 | 2 | 2014 |
| IO-125: A novel supramolecular platinum chemotherapy for triple negative breast cancer. A Sengupta, S Mylavarapu, S Kumari, S Hossain, N Gupta, A Sarkar, ... Journal of Clinical Oncology 33 (28_suppl), 153-153, 2015 | 1 | 2015 |
| Immune memory induction by platinum based compounds S Sengupta, A Sengupta, S Mylavarapu, ROY Monideepa | | 2019 |
| IDENTIFICATION AND CHARACTERIZATION OF NOVEL MOLECULER MARKERS IN CENCER PREVALENT AMONGINDIAN PATIENTS S MYLAVARAPU | | 2019 |
| IO125 is a potent inducer of tumor immunogenicity S Mylavarapu, S Kaushik, Y Yadav, M Roy, A Sengupta, S Sengupta Cancer Research 76 (14_Supplement), 2231-2231, 2016 | | 2016 |
| Abstract P5-03-03: Designing a novel platinum chemotherapeutic (IO-125) for treatment of breast cancer A Sengupta, M Roy, A Sarkar, S Mylavarapu, S Modi, N Gupta, S Hossain, ... Cancer Research 76 (4_Supplement), P5-03-03-P5-03-03, 2016 | | 2016 |
